We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Block me then! Obvs you are now also a medical expert and can absolutely guarantee something that even the pharmaceutical companies won’t (as they have no legal liability regarding any claims). It’s the broad categorisation of anybody who might have even the slightest misgivings - as anti-vaxxers (a phrase you learned whilst ‘researching’ no doubt! Haha!!!!
Well, we've all had losers. DEV wasn't my biggest win of 2021. Haven't lost anything on TGR as I'm in profit and still hold every share I ever bought.
I'm not into anti-vax (in fact I block anyone who spouts such irritating nonsense), and don't really discuss Brexit but yeah I talk discuss covid and share on Twitter. So what?
I do know about buying into speculative stuff, but I prefer to do that when the company is cheaply valued, not with a load of hype and expectation baked in.
Old Bobby is back!
He’s taken his medicine on his losers at LND and TGR and come back to the DEV board, the very share which provided him with one of his biggest wins of 2021 in order to discuss a stock he once, but no longer owns!
It’s a very sad state of affairs, and I understand you are likely lonely judging by your continual Twitter engagement with basically anything and anyone that will respond (Covid cases, anti-vax theories, brexit to name but a few).
You should get yourself on a dating site and find yourself a good lady/bloke to occupy your time Bobby!
Jay_P. Hhahhahaha. The thought that my musings can have any impact whatsoever on a quarter of a billion pound market cap. Yeah, pull the other one.
I sold all of my shares here over the summer after my outlook turned bearish and have had no position here since then.
I might re enter if there is a material change to the investment proposition - like some actual figures and a reveal of the Aldebaron smoke and mirrors deal.
I only post on down days, because most days dev is indeed down. There's no agenda. If you don't want to read my musings, hit the mute button.
nomura, cash for equity might be progress. Depends what the cash is used for. I mean the Aldebaron thing is a placing in all but name, particularly the first year of the deal. I'd hardly call a chunk of equity in return for "revenue" about equal to the value of that chunk of equity a brilliant deal for existing shareholders - in fact in some ways that's WORSE than a placing as revenue won't all drop through to the bank balance, if it is indeed revenue.
It all just seems unnecessarily convoluted.
"what we know for next year already" What do we know? In terms of expected revenue figures? EBITDA? EPS?
What made me invest in the first place? It looked like an interesting play on the virtual reality space that was all the rage at the time, with a sideline in SaaS. Was a bit of a punt. Now I don't really know what dev does, or why they have done these deals shrouded in secrecy and what they expect to get from them.
Livelearn. So we know when the Phase 2 rollout is. But what will the revenue be? $ per school/student/total? What's the margin? Nobody knows, but lots of people throwing made up numbers around. Might be great, might be rubbish.
I made a mistake on the half billion, you are right, it's just under a quarter. Still feels a bit toppy to me. Clearly market thinks so to today.
Bob79,
'There's no clue as to actual revenue or timescale of that revenue' - Phase 2 roll out Q1 next year, so we do have some idea
'Valued at half a billion pounds' - actually less than a quarter
I think the majority of us are confident of more great news by the year end
L&L
I would argue that any positive comments on dev have been from investors who are bullish. Nothing like the ramping on aim shares. The deramping, by the likes of yourself has been constant...
It is surely showing great progression? Look at the revenues reported in results compared to what we know for next year already! The Veative deal soon to complete too.
You have mentioned the revenue for equity swap before, either way surely it is progress and cash flow for the company?
What made you invest in the first place? Amazing you try and pick a hole in every announcement.....agenda?
No agenda, just offering a suggestion as to why the market hasn't responded in the way the rampers suggested it would/should.
It's an early stage tech company, with unknown revenues and an unproven model. Valued at half a billion pounds. I'd say there's a lot priced in already, so an "expected" announcement was always going to make the market go "Meh" and shrug its shoulders.
The £50m revenue from Aldebaron is more like a revenue for equity swap. The first years revenue is wholly balanced by equity, so it's effectively a placing.
Bob, you have had an agenda with Dev for a long time.
They have minimum revenue of $50 over the coming years separate to the revenue announced today, although we are yet to know that. But they aren't doing it for nothing as you seem to think. If it wasn't going well, why would they progress to stage 3? This is only revenue in India too.....
Really odd that you continue to comment on DEV....agenda?
Market cap already priced for a lot of good news/contracts. Still no visibility of actual revenue. Hence muted market reaction - no reason to suspect that todays announcement will encourage lots of buying because:
It was expected
There's no clue as to actual revenue or timescale of that revenue
Company already highly priced, so a small disappointment could have a big impact on price.
In summary, lots of downside risk and todays announcement doesn't really help build confidence to the upside further than it already has built.
It’s an unrecognised market to the blind .
So the sp doesn’t respond immediately .
Watch by the end of the week.
No brainier
Just patience and insight
News while great was expected and already baked in the SP to some degree. Traders, profit takers, market makers..... plus the usual smoke and mirrors ; )
Patience is key
The is but a puppy
Ok, I'm fairly new to investing but I still can't fathom out how a company can release news that effectively says "we have a significant new income stream with opportunities to expand it further" and the share price falls!!!